Journal
AGING-US
Volume 13, Issue 3, Pages 4335-4356Publisher
IMPACT JOURNALS LLC
Keywords
MSCs; CUEDC2; OGD/R; MCAO
Categories
Funding
- National Nature Science Foundation of China [81801188, 81974213]
Ask authors/readers for more resources
The study investigated the role of CUEDC2 in cerebral ischemic stroke and whether CUEDC2-modified MSCs could improve the efficacy of treatment, finding that siRNA-CUEDC2 in MSCs significantly enhanced therapeutic effects by upregulating GPX1 expression levels and suppressing NF-kB activation in co-cultured neurons. These findings suggest a promising strategy for utilizing MSCs to promote outcomes in cerebral ischemic stroke.
Mesenchymal stem cell (MSC) therapy has been reported to be a promising therapeutic option for cerebral ischemia/reperfusion (I/R) insult. However, the poor survival rate of engrafted MSCs under unfavorable cerebral I/R-induced microenvironment inhibits their efficiency during clinical application. CUE domain-containing 2(CUECD2) exhibits its protective role on cardiomyocytes by mediating the antioxidant capacity. Our study explored the functional role of CUEDC2 in cerebral I/R challenge and determined whether CUECD2-modified MSCs could improve the efficacy of treatment of the insulted neurons. We also evaluated the possible mechanisms involved in cerebral I/R condition. Cerebral I/R stimulation suppressed CUEDC2 levels in brain tissues and neurons. siRNA-CUEDC2 in neurons significantly inhibited cerebral I/R-induced apoptosis and oxidative stress levels in vitro. Moreover, siRNA-CUEDC2 in the MSCs group remarkably enhanced the therapeutic efficacies in cerebral I/R-induced neuron injury and brain tissue impairment when compared to the non-genetic MSCs treatment group. At the molecular level, siRNA-CUEDC2 in MSCs markedly enhanced its antioxidant and anti-inflammatory effect in co-cultured neurons by upregulating glutathione peroxidase 1 (GPX1) expression levels while suppressing NF-kB activation. These findings provide a novel strategy for the utilization of MSCs to promote cerebral ischemic stroke outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available